Stéphane Epelbaum

6PUBLICATIONS
14CO-AUTHORS
Disease surveillanceGerman languageEthical use of new technologyMemory and attentionEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 30, 2026
Sleep-like slow waves during resting-state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease.

|May 13, 2021
Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Nonamyloid Logopenic Variant.

Dario Saracino, Sophie Ferrieux, Marie Noguès-Lassiaille

|Jan 18, 2021
The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.

Timothy Daly, Ignacio Mastroleo, David Gorski

|Oct 15, 2020
Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD.

Federica Cacciamani, Luisa Sambati, Marion Houot

|Jun 27, 2019
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Stéphane Epelbaum, Claire Paquet, Jacques Hugon

Pageof 1

Frequent Collaborators

2 joint publications

Timothy Daly

1 joint publications

Ignacio Mastroleo

1 joint publications

David Gorski

1 joint publications

Dario Saracino